Nuformix plc (NFX) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.296x

Based on the latest financial reports, Nuformix plc (NFX) has a cash flow conversion efficiency ratio of -0.296x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-223.56K ≈ $-27.20 USD) by net assets (GBX754.93K ≈ $91.85 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Nuformix plc to measure how much of total assets are equity-financed.

Nuformix plc - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Nuformix plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Nuformix plc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Nuformix plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nuformix plc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Unicorn Mineral Resources PLC LSE:UMR	N/A
AETHER CATALYST SOLUT. F:2QZ	0.511x
World Chess PLC LSE:CHSS	0.034x
Cykel AI PLC LSE:CYK	-2.040x
Electricity Generating Public Company Limited F:ECGF	0.000x
Hamak Gold Ltd LSE:HAMA	0.000x
DongBang Medical KQ:240550	N/A
Thruvision Group PLC LSE:THRU	-0.076x

Annual Cash Flow Conversion Efficiency for Nuformix plc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Nuformix plc from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Nuformix plc market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-09-30	GBX754.93K ≈ $91.85	GBX-614.61K ≈ $-74.78	-0.814x	-75.53%
2024-09-30	GBX715.57K ≈ $87.06	GBX-331.88K ≈ $-40.38	-0.464x	-256.20%
2023-09-30	GBX4.20 Million ≈ $510.41	GBX-546.23K ≈ $-66.46	-0.130x	-27.12%
2023-03-31	GBX4.23 Million ≈ $514.45	GBX-433.10K ≈ $-52.70	-0.102x	+63.94%
2022-03-31	GBX4.74 Million ≈ $576.47	GBX-1.35 Million ≈ $-163.73	-0.284x	-90.40%
2021-03-31	GBX5.69 Million ≈ $691.85	GBX-848.22K ≈ $-103.20	-0.149x	+2.77%
2020-03-31	GBX4.74 Million ≈ $577.03	GBX-727.60K ≈ $-88.53	-0.153x	-95.54%
2019-03-31	GBX3.82 Million ≈ $464.22	GBX-299.34K ≈ $-36.42	-0.078x	+76.98%
2018-03-31	GBX4.49 Million ≈ $546.69	GBX-1.53 Million ≈ $-186.31	-0.341x	-112.33%
2017-03-31	GBX-179.59K ≈ $-21.85	GBX-496.32K ≈ $-60.39	2.764x	+496.03%
2016-03-31	GBX502.34K ≈ $61.12	GBX-350.55K ≈ $-42.65	-0.698x	-89021.82%
2015-07-31	GBX-110.86K ≈ $-13.49	GBX86.80 ≈ $0.01	-0.001x	-224.10%
2014-07-31	GBX247.00K ≈ $30.05	GBX155.85 ≈ $0.02	0.001x	--

About Nuformix plc

LSE:NFX UK Biotechnology

Market Cap

$37.22K

GBX305.91 Million GBX

Market Cap Rank

#31539 Global

#1230 in UK

Share Price

GBX0.15

Change (1 day)

+4.32%

52-Week Range

GBX0.08 - GBX0.49

All Time High

GBX13.75